Neurologic Disorders Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00016897
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Neurologic Disorders Therapeutics Market Scope, Growth, Size and Share by 2031

Buy Now

Neurologic Disorders Therapeutics Market Report Neurologic Disorders Therapeutics Market Size and Share Neurologic Disorders Therapeutics Market Scope and Analysis

Neurologic Disorders Therapeutics Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Indication
  • Parkinson Diseases
  • Alzheimer Diseases
  • Psychotic Disorders
  • Epileptic Disorders
  • Autism Disorders
  • Brain Tumor Diseases
By Drug Class
  • ACE Inhibitors
  • NMDA Antagonist
  • D2 Antagonists
By Application
  • Central Nervous System
  • Peripheral Nervous System
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Biogen Inc
  • F Hoffmann La Roche Ltd
  • Johnson Johnson Services Inc
  • Novartis AG
  • Pfizer Inc
  • Sage Therapeutics Inc
  • Boehringer Ingelheim International GmbH
  • Bayer AG
  • GlaxoSmithKline plc